The NHLBI has a long history of supporting groundbreaking research to prevent, detect, and treat heart, lung, blood, and sleep disorders and diseases. Each year, we invest more than $3 billion in medical research in NHLBI laboratories and at more than 520 research institutions across the country and world.
Research In Action
Congressional Budget Justifications
Each year, when the President submits a budget request to Congress, federal agencies including the NIH/NHLBI prepare a Congressional Justification for the House and Senate appropriations committees. This document helps justify the President's request by detailing our past investments and advances in research, active research programs, evolving scientific priorities, and proposed budget for the coming fiscal year (FY).
*Some CJ files may be undergoing remediation for compliance with Section 508, especially tabular data embedded as images.
Each year, Congress issues directives, called Significant Items, to Federal agencies, including NIH, in the reports accompanying House and Senate appropriations bills. Significant Items are assigned to the NIH Institutes and Centers (ICs) according to their areas of expertise.
Congressional Appropriations Hearings
Each year, the NHLBI Director may be called upon to testify before the House and Senate Appropriations Subcommittees on Labor, Health and Human Services, and Education, and Related Agencies (LHHS).
Explore past Statements for the Record:
Congressional Testimony, Briefings, Reports, and Special Events
The NHLBI is accountable to keeping Congress informed about Institute-funded research. Occasionally, NHLBI subject matter experts are asked to testify before Congress or participate in Congressional briefings and events.
- FY 2022 Senate Appropriations Labor-HHS Subcommittee. (May 26, 2021) NHLBI Speaker: Gary H. Gibbons, M.D., NHLBI Director, joins NIH Director Collins and several other NIH Institute Directors.
- FY 2022 House Appropriations Labor-HHS Subcommittee. (May 25, 2021) NHLBI Speaker: Gary H. Gibbons, M.D., NHLBI Director, joins NIH Director and several other NIH Institute Directors.
- Black Maternal Health Caucus Roundtable. (December 11, 2019) NHLBI speaker: Gary H. Gibbons, M.D., NHLBI Director.
- Labor-HHS Subcommittee members visit NIH. (September 17, 2019) NHLBI speaker: John Tisdale, M.D., Division of Intramural Research.
- The Alliance of Aging Research 2019 Annual Congressional Bipartisan Awards (September 17, 2019) John Tisdale, M.D. of NHLBI received Silver Innovator Award.
- Congressional Rare Disease Caucus Briefing on New Technologies and Treatments for Rare Diseases (May 15, 2019) NHLBI Speaker: Gary H. Gibbons, M.D., NHLBI Director.
- Capitol Hill Event to Commemorate the NHLBI Division of Lung Diseases (DLD) 50th Anniversary (April 9, 2019)
- Research! America 30th Annual Meeting of Members (March 13, 2019) NHLBI Speaker: Gary H. Gibbons, M.D., NHLBI Director.
- WomenHeart Capitol Hill Briefing on Women’s Inclusion in Cardiovascular Research (February 26, 2019) NHLBI Speakers: Gary H. Gibbons, M.D., NHLBI Director, and Nakela Cook, M.D., Chief of Staff at NHLBI
- Pulmonary Fibrosis Patient Education Day, (September 22, 2018) NHLBI Speaker: Gary H. Gibbons, M.D., NHLBI Director
- Congressional Briefing on Chronic Obstructive Pulmonary Disease: The Burden in Rural America, (March 20, 2018) NHLBI Speaker: James, P. Kiley, Ph.D., director of the Division of Lung Diseases
Key Moments in NHLBI’s Legislative History
The National Heart Institute was established in 1948 when President Harry S. Truman signed into law the National Heart Act, Public Law 80-655, which authorized the Institute to conduct, assist, and foster research; provide training; and assist the states in the prevention, diagnosis, and treatment of heart diseases.
The Institute was renamed the National Heart and Lung Institute in 1969 by the U.S. Secretary of Health, Education, and Welfare, after a major National Heart Institute reorganization that created a pulmonary disease branch, along with branches for other cardiovascular diseases, therapeutic evaluation, and epidemiology.
Congress further expanded the Institute’s authorities in 1972, with the enactment of the National Heart, Blood Vessel, Lung and Blood Act, Public Law 92-423, to augment the national effort against heart, lung, and blood diseases.
In 1976, the Health Research and Health Services Amendments, Public Law 94-278, authorized research and training on blood disease and the use of blood products and the management of blood resources. The law also changed the Institute’s name to the NHLBI.
In 1993, the National Center on Sleep Disorders Research was established as part of NHLBI, with the enactment of the NIH Revitalization Act, Public Law 103-43. The Center remains under the leadership of the NHLBI Division of Lung Diseases.
For more information about the NHLBI's history, visit The NIH Almanac.
Annual Science Advances
Advancing Heart, Lung, Blood, and Sleep Research
Learn more about some of NHLBI's major programs, partnership activities, as well as recent advances in research funded by the institute. The information is presented by program area and showcases how NHLBI is implementing the objectives established in the NHLBI Strategic Vision.
NHLBI Gift Fund
The NHLBI is also authorized by Congress to accept donations and bequests to support its mission.
Still can't find what you're looking for?
Science Policy, Outreach, and Reporting (SPOR) Branch
SPOR Branch Chief: Sandeep Dayal, Ph.D.
Office of Science Policy, Engagement, Education and Communications
National Heart, Lung, and Blood Institute